Semaglutide Cost: What to Actually Expect in 2026
GLP-1 pricing ranges wildly depending on brand vs. compounded, insurance vs. cash-pay, and provider markups. Here's the honest breakdown.
The Price Landscape
Brand Name vs. Compounded
Wegovy (brand semaglutide): Manufactured by Novo Nordisk. Retail price exceeds $1,300/month without insurance. With insurance, copays typically range from $25-200/month depending on your plan — but many insurers don't cover it for weight loss, only for diabetes.
Compounded semaglutide: Made by licensed 503A/503B compounding pharmacies using the same active ingredient. Significantly less expensive ($300-500/month through most providers). This is how the majority of telehealth clinics — including Heyday — provide GLP-1 therapy at accessible prices.
What Heyday Charges
Heyday's GLP-1 plans start at $299/month (annual) and include medication, provider oversight, dosing titration, and ongoing monitoring. No hidden fees for consultations or dose adjustments. The medication ships monthly in discreet packaging.
Insurance & HSA/FSA
Most insurance plans cover semaglutide for type 2 diabetes (as Ozempic) but not for weight loss alone. Coverage for Wegovy specifically varies widely. If your plan doesn't cover it, HSA and FSA accounts can be used for GLP-1 medication — paying with pre-tax dollars saves 25-35% effectively.
Is It Worth It?
The average patient loses 15-17% of body weight on semaglutide. For a 230-pound man, that's 35-40 pounds. Beyond the scale, GLP-1 therapy improves blood pressure, cholesterol, blood sugar, and — for men — can raise testosterone levels by 50-100+ ng/dL through visceral fat reduction alone. When you factor in the downstream health costs of obesity (medications, comorbidities, reduced productivity), the investment often pays for itself.